OXBOW ADVISORS, LLC – Eli Lilly and Company Transaction History
OXBOW ADVISORS, LLC portfolio value:
$256,000
portfolio value
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 793 shares | 256K | $323.35 | 793 |
| Q1 2022 | share | Decrease | -100.00% | -975 shares | -269K | $286.37 | 0 |
| Q4 2021 | share | 0.00% | 0 shares | 44K | $277.25 | 975 | |
| Q3 2021 | share | 0.00% | 0 shares | 1K | $230.3 | 975 | |
| Q2 2021 | share | Decrease | -10.14% | -110 shares | 21K | $228.04 | 975 |
| Q1 2021 | share | Increase | 0.00% | 1.08K shares | 203K | $184.81 | 1.08K |
| Q2 2020 | share | Decrease | -100.00% | -1.88K shares | -261K | $160.1 | 0 |
| Q1 2020 | share | 0.00% | 0 shares | 13K | $134.64 | 1.88K | |
| Q4 2019 | share | Increase | 0.00% | 1.88K shares | 248K | $126.91 | 1.88K |
| Q2 2018 | share | Decrease | -100.00% | -5.32K shares | -412K | $79.72 | 0 |
| Q1 2018 | share | Decrease | -2.02% | -110 shares | -47K | $71.78 | 5.32K |
| Q4 2017 | share | Increase | +2.12% | 113 shares | 4K | $77.79 | 5.43K |
| Q3 2017 | share | Decrease | -48.43% | -4.99K shares | -395K | $78.29 | 5.32K |
| Q2 2017 | share | Increase | 0.00% | 10.32K shares | 850K | $74.85 | 10.32K |